Standout Papers

RET, ROS1 and ALK fusions in lung cancer 2009 2026 2014 2020 939
  1. RET, ROS1 and ALK fusions in lung cancer (2012)
    Kengo Takeuchi, Manabu Soda et al. Nature Medicine
  2. KIF5B-ALK, a Novel Fusion Oncokinase Identified by an Immunohistochemistry-based Diagnostic System for ALK-positive Lung Cancer (2009)
    Kengo Takeuchi, Young Lim Choi et al. Clinical Cancer Research

Immediate Impact

1 by Nobel laureates 45 from Science/Nature 91 standout
Sub-graph 1 of 19

Citing Papers

Acetyl-CoA metabolism in cancer
2023 Standout
Lipid metabolism in sickness and in health: Emerging regulators of lipotoxicity
2021 Standout
17 intermediate papers

Works of Yukitoshi Satoh being referenced

ATP Citrate Lyase: Activation and Therapeutic Implications in Non–Small Cell Lung Cancer
2008

Author Peers

Author Last Decade Papers Cites
Yukitoshi Satoh 3425 2547 2108 185 5.7k
Sylvie Lantuéjoul 3603 3076 2035 151 6.6k
Dara L. Aisner 4641 3641 3360 127 7.8k
Koh Furuta 2297 2146 2550 99 5.8k
Kiyotaka Yoh 2533 2911 1319 269 4.5k
Yasunori Sohara 4063 2708 2003 81 5.9k
Noriko Motoi 3256 2497 1394 189 5.5k
Philip C. Mack 3412 3713 2806 233 6.7k
Akira Sakurada 3248 2511 1794 185 5.3k
Hiroshi Nokihara 3287 3801 1635 236 5.8k
Ludovic Lacroix 2215 2684 2673 217 7.3k

All Works

Loading papers...

Rankless by CCL
2026